Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 13,580.00p on 23-01-2026 at 19:40:05
Change 20.00p 0.15%
Buy 13,570.00p
Sell 13,566.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 840.00 at 13,576.00p
Day's Volume: 1,574,503
Last Close: 13,580.00p
Open: 13,702.00p
ISIN: GB0009895292
Day's Range 13,512.00p - 13,704.00p
52wk Range: 9,574.00p - 14,408.00p
Market Capitalisation: £210.53b
VWAP: 13,607.14711p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 840 13,576.00p SI Trade
Negotiated Trade
 16:54:47 - 23-Jan-26
Buy* 5,466 13,590.523p SI Trade
Negotiated Trade
 16:47:06 - 23-Jan-26
Sell* 32,690 13,569.217p SI Trade
 16:37:05 - 23-Jan-26
Unknown* 8,658 13,628.062p Negotiated Trade
OTC Trade
 16:36:37 - 23-Jan-26
Sell* 5,798 13,583.813p SI Trade
Suspected SELL Trade
 16:36:31 - 23-Jan-26
Sell* 9 13,580.00p Automatic Execution
 16:35:30 - 23-Jan-26
Sell* 100 13,580.00p Automatic Execution
 16:35:30 - 23-Jan-26
Sell* 49 13,580.00p SI Trade
 16:35:29 - 23-Jan-26
Sell* 14 13,580.00p SI Trade
 16:35:29 - 23-Jan-26
Sell* 769 13,580.00p SI Trade
 16:35:29 - 23-Jan-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
23rd Jan 2026 (Fri) 13,702.00 13,704.00 13,512.00 13,580.00 1,574,503
22nd Jan 2026 (Thu) 13,540.00 13,604.00 13,428.00 13,560.00 2,673,261
21st Jan 2026 (Wed) 13,482.00 13,496.00 13,292.00 13,338.00 2,379,951
20th Jan 2026 (Tue) 13,786.00 13,786.00 13,268.00 13,520.00 3,045,271
19th Jan 2026 (Mon) 13,994.00 14,188.00 13,890.00 13,890.00 1,536,668
16th Jan 2026 (Fri) 14,020.00 14,154.00 13,972.00 14,052.00 3,712,321
15th Jan 2026 (Thu) 14,326.00 14,408.00 13,982.00 14,026.00 2,722,021
14th Jan 2026 (Wed) 14,080.00 14,396.00 14,072.00 14,346.00 3,068,095
13th Jan 2026 (Tue) 13,978.00 14,060.00 13,804.00 14,008.00 3,158,493
12th Jan 2026 (Mon) 14,036.00 14,266.00 13,882.00 14,120.00 2,193,793
9th Jan 2026 (Fri) 14,010.00 14,330.00 13,974.00 14,216.00 1,510,712
8th Jan 2026 (Thu) 14,030.00 14,292.00 14,022.00 14,176.00 2,489,065
7th Jan 2026 (Wed) 14,050.00 14,312.00 14,038.00 14,224.00 2,010,791
6th Jan 2026 (Tue) 13,400.00 14,114.00 13,392.00 14,038.00 2,053,602
5th Jan 2026 (Mon) 13,644.00 13,644.00 13,278.00 13,384.00 1,631,479
2nd Jan 2026 (Fri) 13,722.00 13,916.00 13,592.00 13,592.00 3,980,211
1st Jan 2026 (Thu) 13,790.00 13,790.00 13,790.00 13,790.00 0
31st Dec 2025 (Wed) 13,768.00 13,844.00 13,722.00 13,790.00 393,700
30th Dec 2025 (Tue) 13,712.00 13,798.00 13,696.00 13,750.00 950,185
29th Dec 2025 (Mon) 13,736.00 13,806.00 13,680.00 13,748.00 1,490,186
26th Dec 2025 (Fri) 13,674.00 13,674.00 13,674.00 13,674.00 0
25th Dec 2025 (Thu) 13,674.00 13,674.00 13,674.00 13,674.00 0
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
20th Jan 2026 7:00 am RNS AstraZeneca to complete direct listing on NYSE
8th Jan 2026 7:00 am RNS AZN new Head of Investor Relations Joris Silon
2nd Jan 2026 3:00 pm RNS Total Voting Rights
22nd Dec 2025 11:00 am RNS Director/PDMR Shareholding
22nd Dec 2025 11:00 am RNS Director/PDMR Shareholding
22nd Dec 2025 7:30 am RNS Enhertu granted BTD for post-neoadjuvant early BC
22nd Dec 2025 7:30 am RNS Enhertu granted BTD for post-neoadjuvant early BC
22nd Dec 2025 7:00 am RNS Update on LATIFY Phase III trial of ceralasertib
22nd Dec 2025 7:00 am RNS Update on LATIFY Phase III trial of ceralasertib
19th Dec 2025 11:00 am RNS Director/PDMR Shareholding
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

PRESS: HSBC chair to join PM Starmer on China visit next week - Sky

22nd Jan 2026 12:29

(Alliance News) - HSBC Holdings Chair Brendan Nelson is among senior business figures set to travel to China with UK Prime Minister Keir Starmer next week, as the government seeks to reset relations with Beijing, Sky News reported on Thursday. Read More

Daiichi and AstraZeneca's Enhertu wins sixth approval in China

22nd Jan 2026 11:21

(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Thursday said Chinese regulators have approved their jointly developed drug Enhertu to treat gastric cancer. Read More

LONDON MARKET CLOSE: Stocks rally as Trump calms Greenland rhetoric

21st Jan 2026 17:01

(Alliance News) - The FTSE 100 shrugged off a weak start to close slightly higher on Wednesday after US President Donald Trump said he would not use force to take control of Greenland, but insisted the US must still have "ownership" of it. Read More

UK-China business forum to be revived during expected PM Starmer trip

21st Jan 2026 09:57

(Alliance News) - The UK and China will seek to re-establish a business dialogue of top executives during UK Prime Minister Keir Starmer's widely-expected visit to Beijing, Reuters reported Wednesday. Read More

LONDON MARKET MIDDAY: Stocks sink as Greenland tensions hit sentiment

20th Jan 2026 12:06

(Alliance News) - Stock prices in London were lower at midday on Tuesday, as the ongoing tension between the US and Europe over Greenland rattled investor sentiment. Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,143.44
Change-6.61

Login to your account

Forgot Password?

Not Registered